Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ampco Pittsburgh (AP) Cash & Equivalents (2016 - 2025)

Ampco Pittsburgh's Cash & Equivalents history spans 14 years, with the latest figure at $15.0 million for Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 26.29% year-over-year to $15.0 million; the TTM value through Sep 2025 reached $15.0 million, up 26.29%, while the annual FY2024 figure was $15.4 million, 111.73% up from the prior year.
  • Cash & Equivalents for Q3 2025 was $15.0 million at Ampco Pittsburgh, up from $9.9 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $18.3 million in Q1 2021 and bottomed at $6.1 million in Q3 2023.
  • The 5-year median for Cash & Equivalents is $9.9 million (2025), against an average of $10.3 million.
  • The largest annual shift saw Cash & Equivalents crashed 62.82% in 2022 before it soared 111.73% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $10.3 million in 2021, then dropped by 15.5% to $8.7 million in 2022, then dropped by 16.59% to $7.3 million in 2023, then skyrocketed by 111.73% to $15.4 million in 2024, then fell by 3.04% to $15.0 million in 2025.
  • Per Business Quant, the three most recent readings for AP's Cash & Equivalents are $15.0 million (Q3 2025), $9.9 million (Q2 2025), and $7.1 million (Q1 2025).